Abstract:The transgenic adenocarcinoma of the mouse prostate (TRAMP) model is based on probasin promoter-driven expression of SV40 T-antigen (Tag) to inactivate p53 and Rb tumor suppressor to propel proliferative lesions and aggressive cancers in the prostate. The genetic background of mice (FVB vs. C57BL/6) has been known to profoundly affect the pathogenesis profiles and disease severity. A recent study suggested prostate lobe specificity of neuro-endocrine (NE) carcinomas vs. glandular epithelial lesions, challenging the classical notion of single-lineage disease progression from early epithelial lesions to poorly differentiated carcinomas. Because of the increasing use of this model for chemoprevention studies, it is critical to further characterize the lobe-specificity of lesion lineages in the prostate and determine their responses to chemopreventive agents. To this end, we carefully dissected the dorsolateral (DLP) and ventral prostate (VP) and macroscopic tumors from 30 male C57BL/6 TRAMP mice at 24-weeks of age and fixed tissues in 10% formalin for pathology diagnosis. Our results show that macroscopic tumors were Tag + , synaptophysin (Syp) + , androgen-receptor (AR) − and E-cadherin − NE carcinomas (poorly differentiated carcinomas) and were dissected exclusively from VP, not DLP. Lesions identified in lymph node, liver or lung of such NE-carcinoma bearing mice showed concordant patterns of biomarkers with the primary prostate NE-carcinomas and represent their metastases. In the DLP, we found lesions ranging from mild (formerly as low grade PIN), moderate to atypical hyperplasia of Tag (formerly as moderately differentiated adenocarcinoma) with Tag + , AR + and E-cadherin + expression and no NE-carcinoma. For assessing the impact of selenium on the long term survival from different lineages of prostate lesions, we analyzed archival tissues from a survival study published recently (Wang et al, Cancer Prev Res 2009): TRAMP mice received a daily oral dose of 3 mg Se/kg body weight as methylseleninic acid (MSeA) beginning at 10 weeks (n=31) or 16 weeks of age (n=30), or water (n=31) until euthanasia or 50 weeks of age. MSeA supplementation significantly delayed death from NE-carcinomas (30% life-time incidence). MSeA also prolonged survival of mice with enlarged seminal vesicle containing epithelial-stromal tumors that were Tag + , Syp − , E-cadherin + and AR +/low in the older TRAMP mice (>30 weeks). Interestingly, mice with enlarged seminal vesicle often had normal sized prostate. In summary, the C57BL/6 TRAMP mouse model represents two lineages of prostate carcinogenesis with an involvement of seminal vesicle tumorigenesis in older mice. Future chemoprevention studies should incorporate this new knowledge for efficacy assessment and for molecular target validations. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 949.

Abstract 3701: Tomato Carotenoids and Testosterone Modulate Mrna and Mirna Profiles During Prostate Carcinogenesis.

Orchestration of Mirna Patterns by Testosterone and Dietary Tomato Carotenoids During Early Prostate Carcinogenesis in TRAMP Mice

Chemomodulatory Efficacy of Lycopene on Antioxidant Enzymes and Carcinogen-Induced Cutaneum Carcinoma in Mice

Supplementary Table S3 from Dietary Tomato and Lycopene Impact Androgen Signaling- and Carcinogenesis-Related Gene Expression During Early TRAMP Prostate Carcinogenesis

Supplementary Table S4 from Dietary Tomato and Lycopene Impact Androgen Signaling- and Carcinogenesis-Related Gene Expression During Early TRAMP Prostate Carcinogenesis

Supplemental Figure S1 from Dietary Tomato and Lycopene Impact Androgen Signaling- and Carcinogenesis-Related Gene Expression During Early TRAMP Prostate Carcinogenesis

Tomatoes, Lycopene, and Prostate Cancer: What Have We Learned from Experimental Models?

Tomato products, lycopene, and prostate cancer risk

Effects Of 1 Alpha,25 Dihydroxyvitamin D3 And Testosterone On Mirna And Mrna Expression In Lncap Cells

Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells

A Novel Tomato-Soy Juice Induces A Dose-Response Increase In Urinary And Plasma Phytochemical Biomarkers In Men With Prostate Cancer

Tomato-based food products for prostate cancer prevention: what have we learned?

Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA

A prospective study of tomato products, lycopene, and prostate cancer risk

Effects of E/Z Isomers of Lycopene on Experimental Prostatic Hyperplasia in Mice

Abstract 5565: Differential Changes of Proteome Profiles in the Dorsal-Lateral Vs. Ventral Prostate of During TRAMP Carcinogenesis

Abstract 5247: Δ-Tocopherol Inhibits the Development of Prostate Adenocarcinoma in Prostate Specific Pten-/- Mice

Inactivation of AR/TMPRSS2-ERG/Wnt Signaling Networks Attenuates the Aggressive Behavior of Prostate Cancer Cells

Lycopene Can Reduce Prostate-Specific Antigen Velocity in a Phase II Clinical Study in Chinese Population

Abstract 949: Different Lineages of Carcinogenesis in Prostate Lobes in the Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Model in C57BL/6 Background and Their Responses to Chemopreventive Selenium

Effects of E/Z isomers of lycopene on experimental prostatic hyperplasia in mice.